Middle-aged Premenopausal Women Research Articles

Influence of the Perimenopause on Cardiovascular Risk Factors and Symptoms of Middle-aged Healthy Women

To determine the changes in cardiovascular risk factors and psychological and physical symptoms that occur during the perimenopause. Cohort study of 541 healthy middle-aged premenopausal women followed up through the menopause. General community. After a baseline evaluation taken at study entry, 152 women ceased menstruating for 3 months (not due to surgery) and were not using hormone replacement therapy, and were reevaluated in a similar protocol (perimenopausal examination); 105 of the 152 were evaluated a third time when they had ceased menstruating for 12 months and were not using hormone replacement therapy (postmenopausal examination). One hundred nine premenopausal women who were repeatedly tested constituted a comparison group. Levels of lipids and lipoproteins, triglycerides, fasting glucose and insulin, blood pressure, weight, height, and standardized measures of psychological symptoms. Women who became perimenopausal showed increased levels of cardiovascular risk factors, which were similar in magnitude to those experienced by the comparison group of premenopausal women. Perimenopausal women reported a greater number of symptoms, especially hot flashes, cold sweats, joint pain, aches in the skull and/or neck, and being forgetful; reports of hot flashes at the perimenopausal examination were associated with low concentrations of serum estrogens. Menopausal status was not associated with depressive symptoms. Perimenopausal women who became postmenopausal showed a decline in the level of high-density lipoprotein-2-cholesterol (means, 0.53 to 0.43 mmol/L [20.6 to 16.7 mg/dL]) and a gradual increase in the level of low-density lipoprotein cholesterol (means, 3.14 to 3.33 mmol/L [121.3 to 128.8 mg/dL]), whereas symptom reporting declined. During mid-life, women experience adverse changes in cardiovascular risk factors and a temporary increase in total number of reported symptoms, with no change in depression. Preventive efforts to reduce the menopause-induced increase in cardiovascular risk factors should begin early in the menopausal transition.

Myths and realities of the menopause.

Menopause is a reproductive milestone in a woman's life around which many different myths have developed. We reviewed three sets of myths that middle-aged premenopausal women hold and evaluated those myths according to scientific data from our own work and that of others. First, middle-aged women expect to experience depression, irritability, and vasomotor symptoms during the menopause. It appears that the vast majority of postmenopausal women do not experience depression, but do experience vasomotor symptoms that are uncomfortable and may have secondary effects on psychological well being, especially during the perimenopause. Second, middle-aged women believe that holding negative expectations about the menopause affects the quality of the menopausal experience. Indeed, that appears to be the case, perhaps because myths can function as self-fulfilling prophecy. The third myth is that there are no important changes that occur during the menopause. That is incorrect. Estrogen deficiency during the menopause sets the stage for substantial changes in risk for CHD, which becomes clinically apparent later in life. We discussed how estrogen deficiency may influence both lipids and lipoprotein levels and the magnitude of neuroendocrine and cardiovascular respond to mental stress. That latter pathway is of particular interest because middle-aged women may be exposed more often to interpersonal stress and may respond more emotionally to it, relative to men, suggesting a potential interactive effect of the decline in reproductive hormones and co-occurring social and psychological changes during the menopausal period. This discussion of the myths and realities of the menopause has deliberately not been exhaustive.(ABSTRACT TRUNCATED AT 250 WORDS)

Comparison of the lipoprotein and hemostatic changes after a triphasic and a monophasic low dose oral contraceptive in premenopausal middle-aged women

Metabolic and hemostatic effects of 2 low dose oral contraceptives (OCs), a triphasic (ethinylestradiol +( - )-norgestrel) and a monophasic (ethinylestradiol + desogestrel) preparation, were compared in a cross-over trial in fertile women over 35 years of age. Both combinations moderately affected plasma lipids, with 17–24% increases of total triglyceridemia. Triglycerides accumulate in low density lipoproteins, thus suggesting the possible formation of an atherogenic lipoprotein particle. Only the monophasic preparation increased high density lipoprotein (HDL)-cholesterol levels significantly, with a rise in HDL 3 mass and cholesterol. OC treatment led to slight changes in HDL 2 and HDL 3 structure, with a rise of the cholesteryl ester and triglyceride contents, indicative of a stimulated cholesterol esterification and reverse transport. Changes in the hemostatic indexes (fibrinogen, antithrombin III and protein C) were negligible. The new low dose OCs, even when prescribed to relatively older women, affect to a relatively small extent lipid/lipoprotein metabolism, with the exception of changes in the low density lipoprotein composition.

Physical activity and cardiovascular risk: A cross-sectional study of middle-aged premenopausal women

The relationship between self-reported physical activity and cardiovascular risk factors was evaluated in a population-based sample. The sample included 541 premenopausal women recruited for a study of the natural history of risk factor change associated with change in sex hormone status. Physical activity was assessed using the Paffenbarger Activity Questionnaire. Women were classified according to quartile of weekly energy expenditure into groups of 0–500, 501–999, 1,000–1,999, and 2,000 kcal or greater. Results showed that the more active the women, the lower their blood pressure and heart rate. More active women had lower cholesterol and triglycerides, and higher high-density lipoprotein (HDL) cholesterol. Tricep and suprailiac skinfolds, fasting insulin, and insulin/glucose levels were also lower among the more active women. When the analysis was repeated controlling for the effect of education and body mass index, the statistical test for linear trend remained significant except for the trend for heart rate, total cholesterol, and triglycerides. Women reporting activity of 1,000 kcal/week had higher high-density lipoprotein cholesterol and lower diastolic blood pressure, body mass index, skinfolds, fasting insulin, and fasting insulin/glucose ratios compared with women reporting lower levels of activity. Only those women who reported 2,000 kcal/week had significantly lower total cholesterol, triglycerides, and low-density lipoprotein cholesterol, and higher HDL 2 cholesterol; women reporting less activity did not differ with regard to these lipids and lipoproteins. The study suggests that physical activity is associated with improved cardiovascular risk profiles among middle-aged women and that the beneficial effects of activity are seen at different levels for specific risk factors.